Filed: 8/15/2025ACC: 0000950123-25-008462
📋 What this filing means
COLUMN GROUP LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $65.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$65.72M
Total AUM (reported)
15.77M
Total Shares
Allocation by class
COM$65.72M100.0%
Portfolio Concentration
Top 3$59.98M91.3%
4–10$5.75M8.7%
Top 3 weight
91.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 15.77M
Sole
Full voting authority
15.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ORIC Pharmaceuticals Inc.
SOLEShares3.54M
TypeSH
Market value$35.94M
54.68%
Sole
3.54M
Shared
0.00
None
0.00
Surrozen, Inc.
SOLEShares1.50M
TypeSH
Market value$13.41M
20.40%
Sole
1.50M
Shared
0.00
None
0.00
RAPT Therapeutics Inc
SOLEShares1.33M
TypeSH
Market value$10.63M
16.17%
Sole
1.33M
Shared
0.00
None
0.00
Tenaya Therapeutics, Inc.
SOLEShares9.40M
TypeSH
Market value$5.74M
8.74%
Sole
9.40M
Shared
0.00
None
0.00
Revolution Medicines Inc
SOLEShares46.00
TypeSH
Market value$1.7K
<0.01%
Sole
46.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ORIC Pharmaceuticals Inc.SOLE | COM | 3.54M | SH | $35.94M 54.68% | 3.54M | 0.00 | 0.00 |
Surrozen, Inc.SOLE | COM | 1.50M | SH | $13.41M 20.40% | 1.50M | 0.00 | 0.00 |
RAPT Therapeutics IncSOLE | COM | 1.33M | SH | $10.63M 16.17% | 1.33M | 0.00 | 0.00 |
Tenaya Therapeutics, Inc.SOLE | COM | 9.40M | SH | $5.74M 8.74% | 9.40M | 0.00 | 0.00 |
Revolution Medicines IncSOLE | COM | 46.00 | SH | $1.7K <0.01% | 46.00 | 0.00 | 0.00 |